A postoperative scoring system for distant recurrence in node-positive cervical cancer patients after radical hysterectomy and pelvic lymph node dissection with para-aortic lymph node sampling or dissection

作者：Lee Young Jae; Kim Dae Yeon^*; Lee Shin Wha; Park Jeong Yeol; Suh Dae Shik; Kim Jong Hyeok; Kim Yong Man; Kim Young Tak; Nam Joo Hyun

来源：Gynecologic Oncology, 2017, 144(3): 536-540.

DOI：10.1016/j.ygyno.2017.01.001

• Recurrence
• Cervical cancer
• Lymphatic metastasis
• Nomogram
• Consolidation chemotherapy

Objective. To identify risk factors for distant recurrence in node-positive cervical cancer patients who underwent radical hysterectomy and pelvic lymph node dissection (PLND) with para-aortic lymph node sampling (PALNS) or para-aortic lymph node dissection (PALND).
Methods. A total of 299 patients in whom lymph node metastasis was confirmed after radical surgery at Asan Medical Center for stage IA2 to BB cervical cancer from February 2001 to December 2012 were identified. In all, 72 (24.1%) patients underwent PLND only and 227 (75.9%) underwent PLND with PALNS or PALND. Four patients were excluded due to diagnosed with small cell carcinoma. The clinicopathologic data of 223 patients were retrospectively analyzed. Distant recurrence was defined as recurrence at a site over the pelvic radiation field.
Results. Among all 223 study patients, the mean number of positive lymph nodes was 4.46. There were 54 (24.2%) patients with distant metastasis. Multivariate analyses using the Cox proportional hazards model showed that histologic types (HR = 3.031, P <= 0.001 for adenocarcinoma, HR = 2.302, P = 0.066 for adenosquamous carcinoma), number of positive lymph nodes (HR = 1.077, P <= 0.001), and surgical stage (HR = 1.264,P = 0.022) were independent risk factors for distant recurrence of cervical cancer. A scoring system for the prediction of distant recurrence was generated by incorporating these factors and showed good discrimination and calibration (concordance index of 0.753). In an internal validation set, this scoring system showed good discrimination with a C-statistics of 0.777. According to the Hosmer-Lemeshow test, the chi-square was 0.650 and the P-value was 0.723.
Conclusions. We have developed a robust scoring system that can predict the risk of distant recurrence in node-positive cervical cancer patients after radical operation. This scoring system was used to identify a group of patients who required systemic control of distant micrometastasis. This group of patients is an appropriate target for consolidation chemotherapy after concurrent chemoradiation therapy.

• 出版日期2017-3